Curie: The Oncology Brief

Curie: The Oncology Brief

Por: Curie: The Platform for HCPs
Catch up quickly with The OncoBrief, your weekly digest of the top three oncology stories that matter most. Delivered clearly and concisely, we cover clinical breakthroughs, FDA approvals, and emerging trends keeping oncologists informed and ahead.
20 episodios disponibles

Latest episodes of the podcast Curie: The Oncology Brief

Radiation Oncology Consolidation, Neuropathy Prevention, and New Immunotherapy for HCC 21/03/2025
MRD in AML, Early-Phase Cancer Trials Reality Check, and the Hospital-at-Home Debate 21/03/2025
Datopotamab Deruxtecan Approved, Immunotherapy Timing, and Rising Early-Onset Colorectal Cancer 21/03/2025
ASCO Ovarian Cancer Guidelines, Mammo-50 Breast Cancer Surveillance, and NRG1 Fusion Therapy Advances 21/03/2025
New Approvals in Oncology: Vimseltinib for TGCT, Sotorasib for KRAS G12C CRC, and Immunotherapy in ER Positive Breast Cancer 21/03/2025
PSA Screening Debate, Brain Metastases in HER2 Positive Breast Cancer, and Subcutaneous Immunotherapy 21/03/2025
Next-Gen Cancer Treatments: HER2-Mutated Breast Cancer, NSCLC ADCs, and FGFR Resistance 21/03/2025
ASCO GI 2025 Highlights: Transforming Gastrointestinal Cancer Care 21/03/2025
Innovations in Oncology: Melanoma Immunotherapy, T-DM1 Advances, and Financial Access Challenges 21/03/2025
Rethinking Cancer Risks: Alcohol Myths, NECTORS in Head & Neck Cancer, and Affordable Breast Cancer Advances 21/03/2025
Oncology Updates: Cetuximab in Head & Neck Cancer, EoE Reassurance, and Oral SERDs for Breast Cancer 21/03/2025
Precision Oncology: MRI-Guided SBRT, HER2+ Breakthroughs, and Sex-Based Insights in MASLD 21/03/2025
ASH 2024 Wrap-Up: Transformative Therapies and Hematology’s Future 21/03/2025
Day 4 Highlights from ASH 2024: Pediatric ALL, Epcoritamab, and a Next-Gen CLL Combo 21/03/2025
Day 3 Highlights from ASH 2024: Lymphoma Breakthroughs and Myeloma Insights 21/03/2025
Day 2 Highlights from ASH 2024: Smoldering Myeloma, CLL Advances, and Ground Zero Insights 21/03/2025
Day 1 Highlights from ASH 2024: Breakthroughs in Sickle Cell Disease and ITP 21/03/2025
ASH 2024 Preview: Breakthroughs, AI, and Game-Changing Advances in Hematology 21/03/2025
Breast Cancer Screening Debate, PI3K Innovations, and AI in Diagnostics 21/03/2025
The Changing Landscape of Rectal Cancer Treatment 21/03/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA